10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      IL‐12 and IL‐4 activate a CD39‐dependent intrinsic peripheral tolerance mechanism in CD8 + T cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Immune responses to protein antigens involve CD4 + and CD8 + T cells, which follow distinct programs of differentiation. Naïve CD8 T cells rapidly develop cytotoxic T‐cell (CTL) activity after T‐cell receptor stimulation, and we have previously shown that this is accompanied by suppressive activity in the presence of specific cytokines, i.e. IL‐12 and IL‐4. Cytokine‐induced CD8 + regulatory T (Treg) cells are one of several Treg‐cell phenotypes and are Foxp3 IL‐10 + with contact‐dependent suppressive capacity. Here, we show they also express high level CD39, an ecto‐nucleotidase that degrades extracellular ATP, and this contributes to their suppressive activity. CD39 expression was found to be upregulated on CD8 + T cells during peripheral tolerance induction in vivo, accompanied by release of IL‐12 and IL‐10. CD39 was also upregulated during respiratory tolerance induction to inhaled allergen and on tumor‐infiltrating CD8 + T cells. Production of IL‐10 and expression of CD39 by CD8 + T cells was independently regulated, being respectively blocked by extracellular ATP and enhanced by an A2A adenosine receptor agonist. Our results suggest that any CTL can develop suppressive activity when exposed to specific cytokines in the absence of alarmins. Thus negative feedback controls CTL expansion under regulation from both nucleotide and cytokine environment within tissues.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          T cell receptor antagonist peptides induce positive selection.

          We have used organ culture of fetal thymic lobes from T cell receptor (TCR) transgenic beta 2M(-/-) mice to study the role of peptides in positive selection. The TCR used was from a CD8+ T cell specific for ovalbumin 257-264 in the context of Kb. Several peptides with the ability to induce positive selection were identified. These peptide-selected thymocytes have the same phenotype as mature CD8+ T cells and can respond to antigen. Those peptides with the ability to induce positive selection were all variants of the antigenic peptide and were identified as TCR antagonist peptides for this receptor. One peptide tested, E1, induced positive selection on the beta 2M(-/-) background but negative selection on the beta 2M(+/-) background. These results show that the process of positive selection is exquisitely peptide specific and sensitive to extremely low ligand density and support the notion that low efficacy ligands mediate positive selection.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            T-bet controls regulatory T cell homeostasis and function during type-1 inflammation

            Several subsets of Foxp3+ regulatory T (Treg) cells work in concert to maintain immune homeostasis. However, the molecular bases underlying the phenotypic and functional diversity of Treg cells remain obscure. We show that in response to interferon-γ, Foxp3+ Treg cells upregulated the T helper 1 (TH1)-specifying transcription factor T-bet. T-bet promoted expression of the chemokine receptor CXCR3 on Treg cells, and T-bet+ Treg cells accumulated at sites of TH1-mediated inflammation. Furthermore, T-bet expression was required for the homeostasis and function of Treg cells during type-1 inflammation. Thus, within a subset of CD4+ T cells, the activities of Foxp3 and T-bet are overlaid, resulting in Treg cells with unique homeostatic and migratory properties optimized for suppression of TH1 responses in vivo.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells.

              Extracellular ATP serves as a danger signal to alert the immune system of tissue damage by acting on P2X or P2Y receptors. Here we show that allergen challenge causes acute accumulation of ATP in the airways of asthmatic subjects and mice with experimentally induced asthma. All the cardinal features of asthma, including eosinophilic airway inflammation, Th2 cytokine production and bronchial hyper-reactivity, were abrogated when lung ATP levels were locally neutralized using apyrase or when mice were treated with broad-spectrum P2-receptor antagonists. In addition to these effects of ATP in established inflammation, Th2 sensitization to inhaled antigen was enhanced by endogenous or exogenous ATP. The adjuvant effects of ATP were due to the recruitment and activation of lung myeloid dendritic cells that induced Th2 responses in the mediastinal nodes. Together these data show that purinergic signaling has a key role in allergen-driven lung inflammation that is likely to be amenable to therapeutic intervention.
                Bookmark

                Author and article information

                Journal
                Eur J Immunol
                Eur. J. Immunol
                10.1002/(ISSN)1521-4141
                EJI
                European Journal of Immunology
                John Wiley and Sons Inc. (Hoboken )
                0014-2980
                1521-4141
                08 April 2016
                June 2016
                : 46
                : 6 ( doiID: 10.1002/eji.v46.6 )
                : 1438-1448
                Affiliations
                [ 1 ] MRC & Asthma UK Centre in Allergic Mechanisms of AsthmaKing's College London UK
                [ 2 ] Purine Research LaboratoryViapath, St Thomas’ Hospital LondonUK
                Author notes
                [*] [* ] Full correspondence: Dr. Alistair Noble, Antigen Presentation Research Group, Imperial College London, Level 7W, Northwick Park & St. Mark's Hospitals, Watford Road, Harrow, HA1 3UJ, UK

                Fax: +020‐8869‐3532

                e‐mail: a.noble@ 123456imperial.ac.uk

                Article
                EJI3595
                10.1002/eji.201545939
                5071739
                26990545
                55a0df98-1d6c-42f4-889c-f3eac533270d
                © 2016 The Authors. European Journal of Immunology published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 20 July 2015
                : 09 February 2016
                : 11 March 2016
                Page count
                Pages: 11
                Funding
                Funded by: Johnson & Johnson and King's College London
                Categories
                Regular Article
                Immunomodulation
                Custom metadata
                2.0
                eji3595
                June 2016
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.5 mode:remove_FC converted:20.10.2016

                Immunology
                cd8+ t cell,cd39,interleukin‐4,interleukin‐12,regulatory t (treg) cell,tolerance
                Immunology
                cd8+ t cell, cd39, interleukin‐4, interleukin‐12, regulatory t (treg) cell, tolerance

                Comments

                Comment on this article